The Effect of Walking in Kidney Transplant Patients

Ege University68 enrolled

Overview

Cardiovascular diseases are among the most common causes of death in kidney transplant patients. Physical activity is of great importance in preventing cardiovascular diseases after transplantation. Although regular physical activity is recommended in international guidelines to prevent post-transplant mortality and morbidity in kidney transplant patients, studies have shown that patients do not follow regular physical activity instructions.The aim of our project is to examine the effect of pedometer-assisted physical activity on metabolic parameters after kidney transplantation.

Patients with kidney transplant surgery will be randomized to the intervention (n: 34) and control groups (n: 34), respectively, according to the transplant surgery date. Intervention and Control groups will be given the same training on the importance of physical activity during discharge training. The pedometer will be given to the intervention group to evaluate the activity level, and it will be said that their goal is to take 2000 steps in 20 minutes a day after discharge. Patients will be asked to carry the pedometer during physical activity, and to write down the number of steps they take in 20 minutes on the form given to them for 90 days. Patients in the control group will only be advised to do physical activity every day and will be asked to record the minutes of physical activity they do for 90 days. Metabolic parameters of the patients in the intervention and control groups will be examined at the end of the 4th and 12th months. These parameters are blood pressure, body mass index, complete blood count (hemoglobin, leukocyte, thrombocyte), blood glucose, sodium, potassium, calcium, liver enzymes, serum creatinine, total and indirect bilirubin, albumin and total cholesterol levels.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Kidney Transplant; Complications Cardiac Disease

Interventions

pedometerDEVICE

2000 steps per day in 20 minutes for 90 days, guided by a pedometer after a kidney transplantation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: • Over the age of 18 and under the age of 65, * Kidney transplantation at the center where the study was conducted between the research dates, * There is no activity restriction recommendation by the physician, * Patients who agree to participate in the study. Exclusion Criteria: * Multiple organ transplantation at the same time, * Death or graft loss/rejection in the hospital before discharge, * Patients with physical activity restrictions by the physician, * Patients who are re-hospitalized within the first 3 months after discharge

Locations (1)

Ege University

Izmir, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

Blood Pressure

mmHg

Time frame: Change from Baseline Blood Pressure at 4 months after discharge

Blood Pressure

mmHg

Time frame: Change from Baseline Blood Pressure at 12 months after discharge

Body Mass Index (BMI)

BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / \[height (m)\]2

Time frame: Change from Baseline BMI at 4 months after discharge

Body Mass Index (BMI)

BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / \[height (m)\]2

Time frame: Change from Baseline BMI at 12 months after discharge

Hemoglobin

g/dL

Time frame: Change from Baseline Hemoglobin at 4 months after discharge

Hemoglobin

g/dL

Time frame: Change from Baseline Hemoglobin at 12 months after discharge

Leukocyte

10\^3/µL

Time frame: Change from Baseline Leukocyte at 4 months after discharge

Leukocyte

10\^3/µL

Time frame: Change from Baseline Leukocyte at 12 months after discharge

Thrombocyte

10\^3/µL

Time frame: Change from Baseline Thrombocyte at 4 months after discharge

Central Contacts

Fatma DEMIR KORKMAZ, Professor

CONTACT

+902323115506 fatma.demir@ege.edu.tr

Tugba Nur ODEN, PhD Student

CONTACT

+902323905106 tugba.nur.zoturk@ege.edu.tr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Thrombocyte

10\^3/µL

Time frame: Change from Baseline Thrombocyte at 12 months after discharge

Blood Glucose

mg/dL

Time frame: Change from Baseline Blood Glucose at 4 months after discharge

Blood Glucose

mg/dL

Time frame: Change from Baseline Blood Glucose at 12 months after discharge

Sodium

mEq/L

Time frame: Change from Baseline Sodium at 4 months after discharge

Sodium

mEq/L